These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11032770)

  • 1. Predicted chemical warfare agent VX toxicity to uniformed soldier using parathion in vitro human skin exposure and absorption.
    Wester RM; Tanojo H; Maibach HI; Wester RC
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):149-52. PubMed ID: 11032770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.
    Dalton CH; Hattersley IJ; Rutter SJ; Chilcott RP
    Toxicol In Vitro; 2006 Dec; 20(8):1532-6. PubMed ID: 16904285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations.
    Vallet V; Cruz C; Licausi J; Bazire A; Lallement G; Boudry I
    Toxicology; 2008 Apr; 246(1):73-82. PubMed ID: 18294748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Hum Exp Toxicol; 2005 Jul; 24(7):347-52. PubMed ID: 16119248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis of organophosphorus hydrolase to enhance hydrolysis of the nerve agent VX.
    Gopal S; Rastogi V; Ashman W; Mulbry W
    Biochem Biophys Res Commun; 2000 Dec; 279(2):516-9. PubMed ID: 11118318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermostyx (IB1) - High efficacy and safe topical skin protectant against percutaneous toxic agents.
    Dachir S; Barness I; Fishbine E; Meshulam J; Sahar R; Eisenkraft A; Amir A; Kadar T
    Chem Biol Interact; 2017 Apr; 267():25-32. PubMed ID: 27417258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):35-8. PubMed ID: 15943757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A physiologically based pharmacokinetic model of organophosphate dermal absorption.
    van der Merwe D; Brooks JD; Gehring R; Baynes RE; Monteiro-Riviere NA; Riviere JE
    Toxicol Sci; 2006 Jan; 89(1):188-204. PubMed ID: 16221965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo toxicological studies of V nerve agents: molecular and stereoselective aspects.
    Reiter G; Müller S; Hill I; Weatherby K; Thiermann H; Worek F; Mikler J
    Toxicol Lett; 2015 Jan; 232(2):438-48. PubMed ID: 25448275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of threshold adverse effect doses of percutaneous VX exposure in African green monkeys.
    Genovese RF; Benton BJ; Oubre JL; Byers CE; Jakubowski EM; Mioduszewski RJ; Settle TJ; Steinbach TJ
    Toxicology; 2011 Jan; 279(1-3):65-72. PubMed ID: 20887765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
    Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dermal absorption of methyl salicylate, ethyl parathion, and malathion: first responder safety.
    Moody RP; Akram M; Dickson E; Chu I
    J Toxicol Environ Health A; 2007 Jun; 70(12):985-99. PubMed ID: 17497409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam.
    Clarkson ED; Schulz SM; Railer RF; Smith KH
    Toxicol Lett; 2012 Aug; 212(3):282-7. PubMed ID: 22698813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine.
    Duncan EJ; Brown A; Lundy P; Sawyer TW; Hamilton M; Hill I; Conley JD
    J Appl Toxicol; 2002; 22(3):141-8. PubMed ID: 12015792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of organophosphate anticholinesterases.
    Cao CJ; Mioduszewski RJ; Menking DE; Valdes JJ; Katz EJ; Eldefrawi ME; Eldefrawi AT
    In Vitro Cell Dev Biol Anim; 1999 Oct; 35(9):493-500. PubMed ID: 10548430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse. (I) Development of a model for screening studies in skin decontamination and protection.
    Dorandeu F; Taysse L; Boudry I; Foquin A; Hérodin F; Mathieu J; Daulon S; Cruz C; Lallement G
    Hum Exp Toxicol; 2011 Jun; 30(6):470-90. PubMed ID: 20547654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection.
    Munro N
    Environ Health Perspect; 1994 Jan; 102(1):18-38. PubMed ID: 9719666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures.
    Mikler J; Tenn C; Worek F; Reiter G; Thiermann H; Garrett M; Bohnert S; Sawyer TW
    Toxicol Lett; 2011 Sep; 206(1):47-53. PubMed ID: 21704135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.